Comparison of the incidence of facial nerve dysfunction in patients submitted to surgery for parotid gland tumors with or without facial nerve monitoring with continuous electromyographic register during the surgery

Facial Nerve Monitoring during superficial parotidectomy for benign tumors of the parotid gland: a prospective randomized trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13966417

Enrollment

150

Registered

2018-03-01

Start date

2015-04-15

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial nerve dysfunction following superficial parotidectomy Surgery Facial nerve dysfunction

Interventions

Participants with benign tumours of the parotid gland undergoing superficial parotidectomy are randomly assigned to the intervention (facial nerve monitoring) or control group on the day of surgery, u

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adult 2. Aged 18 to 85 years 3. Benign parotid tumor(s) 4. Normal neuromuscular facial function prior to surgery

Exclusion criteria

Exclusion criteria: 1. Malignant parotid tumor(s)

Design outcomes

Primary

Measure	Time frame
Incidence of facial nerve dysfunction measured by experienced physicians up to 30 days (immediate) and 180 days (late) following superficial parotidectomy	—

Secondary

Measure	Time frame
Degree of facial nerve dysfunction evaluated by experienced physicians at 30, 90 and 180 days following surgery	—

Countries

Brazil

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026